Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples